Robotics combined with AI machine learning spots Parkinson’s disease signatures.
KEY POINTS
- Over 10 million people worldwide live with Parkinson’s disease, including nearly a million Americans.
- A new study uses AI deep learning that finds cellular disease signatures to help accelerate the discovery of novel therapeutics for Parkinson’s.
- This unique AI deep learning platform solution is not limited to Parkinson’s disease. It can be repurposed for other disease signatures.
Artificial intelligence (AI), machine learning, and robotics are accelerating precision medicine for neurodegenerative diseases and brain disorders.
A new study published in Nature Communications reveals a high-throughput screening platform using AI deep learning that finds cellular disease signatures to help accelerate the discovery of novel therapeutics for Parkinson’s disease (PD).
Continue reading… “AI Speeds Precision Medicine for Parkinson’s Disease”
